Company News

Boviteq is extremely excited to announce the opening of several new licensee locations worldwide. Strategically selected, these new IVF partners combine local intelligence with Boviteq knowledge to deliver clients globally with the industry’s leading IVF services.

Now, clients in Switzerland at Swissgenetics, in France at Evolution, in Western Canada at Bow Valley Genetics, in Italy at Embryovet and in the UK via Paragon Vet Ltd have access to Boviteq’s world-leading technology and services.

“With the global growth in IVF services and the extreme demand we’ve seen for Boviteq worldwide Swissgenetics, Evolution, Bow Valley Genetics, EmbryoVet and Paragon were all logical choices,” says Dany-Pierre Rondeau, Semex Vice President, Embryo Division. “Each brings their own excellent service and client relationships, along with a quality first philosophy that meshes with our own. As producers turn to embryos and IVF for the fastest genetic gain, Boviteq is a real game changer. Our goal is to expand in key markets, bringing worldwide access to Boviteq’s IVF technology.”

"Over the past several months our staff in Saint-Hyacinthe has been working hard to train and accredit staff at each location on our standard operating procedures, techniques and attention to detail,” says Rondeau. “We have no doubt that the quality and service we’re known for is now available in Switzerland, France, Western Canada, Italy and the UK.”

A division of Semex, Boviteq offers the world’s leading reproductive and genetic solutions to its global clients via its world-class laboratories, ground-breaking research and exceptional service.


For additional information on Swissgenetics please visit: https://swissgenetics.com
For additional information on Evolution please visit: http://www.evolution-int.com
For additional information on Bow Valley Genetics please visit: https://bowvalleygenetics.com
For additional information on Embryovet please visit: ... Read More...

Semex is pleased to announce its 2022-2023 Board of Directors with one new member, Jean Bissonnette, joining the Board, replacing outgoing director Mariette Gagnon, representing Centre d'insémination artificielle du Québec (CIAQ).
Phil MacLean will continue to serve as President of the Board (EastGen), assisted by Vice President Jean-François Morin (CIAQ) and Executive Member Curtis McNeil (EastGen). Other members of the Board of Directors include: Normand Barriault (CIAQ); Richard Lagacé (CIAQ); Gerrit Wensink (EastGen); Jean Bissonnette (CIAQ); Tom Pasco (EastGen); and James Ross (WestGen); Tony Van Garderen (WestGen).
Semex is comprised of three Owners: WestGen, CIAQ (Centre d'insémination artificielle du Québec) and EastGen. As a leading global genetics company, Semex is focused on providing our clients with the solutions, innovations and technologies that positively impact their lives, as well as the lives of the animals on their operations and within our global community. This is Genetics for Life, our guiding compass.
Photo Caption: Top from L to R: Phil MacLean, Jean-François Morin, Curtis McNeil; Middle from L to R: Normand Barriault, Jean Bissonnette, Tony Van Garderen; Bottom from L to R: Richard Lagacé, Gerrit Wensink, Tom Pasco, James Ross.
... Read More...

Semex and Boviteq, are excited to announce a partnership started in the Fall of 2021 with world-renown breeders Ferme Jacobs of Cap-Santé, Quebec.

Ferme Jacobs is shifting much of their milk production herd to a state-of-the-art robotic facility for 300+ cows. Being focused on genetic improvement, Semex and Boviteq are pleased to team up with them, utilizing Semex solutions such as Elevate® genomic testing and IVF services from Boviteq. Together, we’re developing a genetic strategy that maximizes genetic gain, producing elite male and female calves, as well as overall herd genetic improvement to meet their future growth strategies.

“We are so pleased to be working more closely with Ferme Jacobs,” said Brad Sayles, Semex Chief Operating Officer. “They’re working hard to invest in their breeding program to not only develop their famous show herd, but also to develop productive, healthy cows that work well in modern management environments. They’re extremely passionate breeders, and excellent ambassadors for the dairy industry, so assisting them in their genetic strategy to reach these goals is certainly an opportunity we’re excited about. Thierry Laberge, Product Development Specialist as well as Semex’s entire genetic team and Pier-Olivier Lehoux, Ciaq Consulting Representative who will work with them to establish objectives, utilizing Semex sires to produce bulls for Semex and elite females for themselves.”

“Additionally, they will be utilizing Boviteq’s world-leading embryo production platform and IVF technologies to maximize embryo production and reproductive performance,” says Sayles.
... Read More...

Semex is pleased to announce that Dr Bonnie Mallard, University of Guelph Professor Ontario Veterinary College, has received the Natural Sciences and Engineering Research Council of Canada (NSERC) Synergy Award and its highest prize of $200,000 towards continuing research. 

Launched in 1995 by NSERC the Synergy Award recognizes partnerships in natural sciences and engineering research and development between universities and Canadian industry. Since their inception, the Awards have honoured the most outstanding achievements of these collaborations in the natural sciences and engineering. 

“When I learned of this win, I was over the moon about this tremendous recognition of my lifetime work as a scientist and professor of immunogenetics,” said Dr. Mallard, adding that the award recognizes women scientists’ ability to translate science into innovation.  
 
“The NSERC Synergy Award for Innovation is one of the highest awards this country offers for innovation, and I plan to use this platform to bring further expansion to the HIR/Immunity+® technology,” she said. “There is still much exciting work left to do.”  
 
Licensed to Semex, the HIR technology has been available to clients worldwide under the Immunity+ lineup since 2012. 
 
“The HIR technology and Immunity+ is a good example of the importance of long-term research collaborations,” says Paul Larmer, Semex CEO. “Nominations are judged on partnership, effective use of resources and tangible benefits, all of which are evident with Immunity+ and HIR testing. We congratulate Dr. Mallard and we’re excited to continue our work together to reduce cattle disease and its related costs through preventative genetic methods worldwide.” 
... Read More...

We are pleased to announce that Jonathan Merriam will be joining Semex August 16, 2021, as Jersey Program Manager, reporting to Jay Shannon, Director, Genetic Programs & Solutions.   “Jonathan is renowned in the Jersey breed for his extensive knowledge, experience and proven leadership in genetics,” says Jay Shannon. “He will utilize all of his acquired skills and extensive knowledge to lead Semex’s genetic programs, working with our elite genetic partner herds to keep raising the bar of our industry-leading Jersey program.”  Jonathan most recently was the Genetics Manager at the 7000-cow Ahlem Farms in Hilmar, California. In this role he led the sire selection, mating and the marketing program for this globally famous Jersey farm and genetic resource. Under Jonathan’s management, Ahlem Farms put over 150 bulls into stud and sold high-value heifers annually in national sales. Previously Jonathan was an agricultural instructor at Utah State University, managing their dairy herd management vocational training program, and was the Dairy Extension Specialist for the University of California Cooperative Extension, advising producers regarding dairy nutrition, reproduction, management, employee relations and environmental regulations.  Jonathan is the current President of the American Jersey Cattle Association, a position he has held for the last three years. He has a rich history of involvement in the dairy industry at local, state and national levels, working on national show and sale committees as well as providing tremendous leadership to youth programs. Jonathan earned his master’s degree in Dairy Science, Dairy Genetics from the University of Wisconsin-Madison and his bachelor’s degree in Dairy Science from California Polytechnic State University. Jonathan resides in Hickman, California with his wife Becca and children Kathryn, Reva, Grace and Nathan.    
... Read More...

Boviteq is extremely excited to announce the opening of Boviteq California in Hilmar, California. Open now, Boviteq California is a fully-operational, accredited Boviteq satellite center offering elite donor housing with OPU and ET services. This location is uniquely equipped to handle young genomic donors, lactating dairy show cows and has robust handling facilities for beef donors.  

“With the growth we’ve seen nationwide for our IVF services and the extreme service demand on the West Coast, California was a logical choice for expansion,” says Dr. Shantille Kruse, Boviteq Director Embryo Business, North America. “Boviteq, and our parent company Semex, have a long-standing relationship with the folks at Vierra Dairy, making them a natural partner for Boviteq California.”

“Our world-class, state-of-the-art IVF (In Vitro Fertilization) facility in Madison, Wisconsin, is ready to accept oocytes from California and for the first time, offer the industry’s best IVF service and results to the West Coast,” says Kruse. “We have seen first-hand the care and quality that Vierra puts into their dairy, and we’ve worked together every step of the way to ensure that this facility, its people and its services meet and exceed industry standards.”

“We’ve been hearing from dairymen for months, asking when we will be ready for them and we’re so excited to let them know that we’re open and ready for business!” says Peter Cipponeri, Vierra Dairy Manager & Boviteq California General Manager. “We really feel that we are offering the very best in donor housing, and coupled with the next level results from Boviteq, Boviteq California will be the most in-demand OPU service provider on the West Coast.”

For additional information on Boviteq please visit ... Read More...

Semex is pleased to announce its 2021-2022 Board of Directors with one new member, Normand Barriault, joining the Board, replacing outgoing director Jean Bissonnette, representing Centre d'insémination artificielle du Québec (CIAQ). Phil MacLean will continue to serve as President of the Board (EastGen), assisted by Vice President Jean-François Morin (CIAQ) and Executive Member Curtis McNeil (EastGen). Other members of the Board of Directors include: Mariette Gagnon (CIAQ); Eric Iversen (WestGen); Richard Lagacé (CIAQ); Gerrit Wensink (EastGen); Tom Pasco (EastGen); and James Ross (WestGen). Photo Caption: Top from L to R: Phil MacLean, Jean-François Morin, Curtis McNeil; Middle from L to R: Normand Barriault, Mariette Gagnon, Eric Iversen; Bottom from L to R: Richard Lagacé, Gerrit Wensink, Tom Pasco, James Ross
... Read More...

Semex is pleased to announce that Phil MacLean (EastGen) has been appointed as President & Chairman of the Board for 2020-2021, succeeding Gary Bowers (CIAQ). Assisting Semex’s new President is Jean-François Morin (CIAQ) as Vice President and Gerrit Wensink (EastGen) as Executive Member of the Board.

Semex President Phil MacLean first joined the Semex Board in 2017, serving on the Audit & Risk Committee from 2017-2020. Representing Semex Partner Owner EastGen, he joined their board in 2016, and was elected Vice President in 2019 and 2020. A native of Nova Scotia, Phil’s farm spans 1300 acres and is a robot operation, now focused on developing an A2A2 herd following the dispersal of his 300-head registered herd, Headline Holsteins. Active in the dairy industry, Phil has served on the boards of the Dairy Farmers of Newfoundland and Labrador, as well as Dairy Farmers of Canada. Phil and his wife Pauline Duivenvoorden also operate Barn Fine Eggs, a 7800-laying hen operation as well as Farm Fine Brood, a 25,000-bird broiler operation. Extremely successful, they were awarded the Outstanding Young Farmers Atlantic Canada Award in 1999.    

Also serving on the Semex Board of Directors are:

Jean Bissonnette (CIAQ)
Mariette Gagnon (CIAQ)
Eric Iversen (WestGen)
Richard Lagacé (CIAQ)
Curtis McNeil (EastGen)
Tom Pasco (EastGen)
James Ross (WestGen)

Semex is comprised of three Partner Owners: WestGen, CIAQ (Centre d'insémination artificielle du Québec) and EastGen. As a leading global genetic company, Semex is focused on providing our clients with the solutions, innovations and technologies that positively impact their lives, as well as the lives of the animals on their operations and within our global community. This is Genetics for Life, our guiding ... Read More...

The Semex Board of Directors and Executive Management Team is excited to announce the creation of a new wholly-owned subsidiary, Semex Mexico, effective October 1, 2020.

“The Mexican dairy industry has seen consistent, steady growth. This is driven by their consumers turning to new healthier dairy products and a growing cheese market, the formation of the Semex Mexico subsidiary is a natural progression of our business,” says Horacio Larrea, Semex Director International Sales & Business Development, Latin America. “Mexico has always been a key market for Semex, with the Mexican dairyman demanding the product, solutions and services Semex is known for worldwide.”

Leading Semex Mexico is Ing Ernesto Padilla de Anda, with seven years of experience working shoulder-to-shoulder with dairymen across Mexico. Ernesto will work with our distribution network around the country, ensuring that Semex’s very best products and programs will be available to Mexican farmers.  

Semex Mexico joins Semex USA, Semex UK, Semex Australia, Semex Argentina, Semex Uruguay, Genbank (Hungary), Semex Deutschland, Semex N.Z. Ltd and Semex China within the Semex-owned subsidiary companies. Along with Ernesto and his distributor network, Semex is committed to Semex Mexico’s future growth and success.

Semex is a leading global genetic company focused on providing our clients with the solutions, innovations and technologies that positively impact their lives, as well as the lives of the animals on their operations and within our global community. This is Genetics for Life, our guiding compass. For more information please visit www.semex.com. For more information on Semex Mexico please visit www.semex.com/mexico
... Read More...

Semex is saddened to announce the passing of one of the most globally popular sires of our time, Val-Bisson Doorman.

 

A one-of-a-kind bull, Doorman was one of the first bulls to greatly benefit from the advent of genomics. His non-genomic parent average gave him modest PTAT and GTPI figures, at breed average. But, with his genomic information, he was released as a proven sire in December 2015 at +4.59 PTAT with a +2439 GTPI, +4.2 PL and a low 2.51 SCS. This, with a pedigree virtually laced with Holstein royalty including Goldwyn, Prelude, Blackstar, Chief Mark, Shottle, Rudolph and Starbuck, it seemed Doorman was born to be the modern transmitter of elite type and show style.

 

“From the moment we introduced him as a Genomax® and Immunity+® sire, he was extremely popular - to the point that even though he was a good producer, he simply could not meet the extreme demand,” says Brad Sayles, Semex Chief Operating Officer.

 

What truly lit the fire in Doorman sales, however, were his daughters. Initially breeders loved their calves and then came back wanting to use him again and again as his milking daughters arrived. With too many Grand Champions and Premier Sire awards to list, breeders everywhere appreciated his dominance regardless of venue or nation – Doorman was the modern Sire of Champions, a legacy to be felt for years upon years to come.

 

For more information on Semex please visit www.semex.com
... Read More...